期刊文献+

2型糖尿病胰岛素治疗方案的选择 被引量:6

原文传递
导出
摘要 糖尿病目前是一个高患病率的慢性疾病,严重危害人类的健康.流行病研究显示2010年全球成年患者约2.85亿(6.4%),2030年将达到4.39亿(7.7%)^[1].其中我国20岁以上糖尿病患者为9240万(9.7%),已经成为全球糖尿病患者最多的国家,其中2型糖尿病(T2DM)患者占绝大多数^[2].研究发现T2DM患者发病时胰岛细胞功能仅剩50%,并且随着糖尿病病程的延长而进行性下降^[3](图1).
作者 李伟 肖新华
出处 《中华糖尿病杂志》 CAS CSCD 2014年第5期281-284,共4页 CHINESE JOURNAL OF DIABETES MELLITUS
  • 相关文献

参考文献24

  • 1Shaw JE, Sieree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030[ J ]. Diabetes Res Clin Praet,2010, 87 : 4-14.
  • 2Yang W, Lu J, Weng J,el al. Prevanlence of diabetes among men and women in China[J]. N Engl J Med,2010,362:1090-1101.
  • 3Kendall DM, Cuddihy RM, Bergenstal RM. Clinical application of ineretin-based therapy: therapeutic potenlial, patienl selection, and clinical use[J]. Am J Med, 2009, 122(6 Suppl) :S37-50.
  • 4Weng J, I,i Y, Xu W, el al. Effect of intensive insulin therapy on [3-cell fimction and glycaemic control in patients with newly diagnosed type :2 diabetes: a multicentre randomised parallel-grouptfialEJ. Lancet, 2008,371:1753-1760.
  • 5UK Prospective Diabetes Study (UKPDS) Group. Intensive blood- glucose control with sulphonylureas or insulincompared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [J]. Lancet, 1998, 352: 837-853.
  • 6UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes( UKPDS 34) [ J]. Lancet, 1998,352 : 854-865.
  • 7Garber AJ, Abrahamson MJ, Barzilay JI, et al. American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement-executive summary[ J ]. Endoer Pract,2013 ,19 :536-557.
  • 8Chaitman BR, Hardison RM, Adler D, et al. The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different trealment strategies in type 2 diabetes mellitus with stable ischemic heart disease : impact of treatment strategy on cardiac mortality and myocardial infarction [ J ]. Circulation,2009, 120:2529-2540.
  • 9Mellbin LG, Malmberg K, Norhammar A, et al. Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glu-eose Infusion in Acute Myocardial Infarction ( DIGAMI ) 2 Study[J ]. Diabetologia, 2011,54 : 1308-1317.
  • 10Gerstein HC, Bosch J, Dagenais GR, et al. Basal insulin and cardiovascular and other outcomes in dysglyeemia [ J ]. N Engl J Med ,2012,367:319-328.

二级参考文献33

  • 1Kirstine Brown Frandsen.糖尿病治疗管理的现状[J].国外医学(内分泌学分册),2005,25(3):172-173. 被引量:28
  • 2潘长玉,中国区合作调查组.中国糖尿病控制现状——指南与实践的差距 亚洲糖尿病治疗现状调查1998,2001及2003年中国区结果介绍[J].国外医学(内分泌学分册),2005,25(3):174-178. 被引量:396
  • 3张巧,胡颖,双倩.心理性胰岛素抵抗的相关因素分析[J].临床荟萃,2005,20(19):1111-1112. 被引量:8
  • 4Hu D,Xie J,Fu P,et al.Central rather than overall obesity is related to diabetes in the Chinese population:.the InterASIA study.Obesity (Silver Spring),2007,15:2809-2816.
  • 5Pan C,Yang W,Jia W,et al.Management of Chinese patients with type 2 diabetes,1998-2006:the Diabcare-China surveys.Curr Med Res Opin,2009,25:39-45.
  • 6Raskin P,Allen E,Hollander P,et al.Initiating insulin therapy in type 2 diabetes:a comparison of biphasic and basal insulin analogs.Diabetes Care,2005,28:260-265.
  • 7Yang W,Ji Q,Zhu D,et al.Biphasic insulin aspart 30 three times daily is more effective than a twice-daily regimen,without increasing hypoglycemia,in Chinese subjects with type 2 diabetes inadequately controlled on oral antidiabetes drugs.Diabetes Care,2008,31:852-856.
  • 8Concato J,Shah N,Horwitz RI.Randomized,controlled trials,observational studies,and the hierarchy of research designs.N Engl J Med,2000,342:1887-1892.
  • 9Korytkowski M. When oral agents fail: pratical barriers to starting insulin. International Journal of Obesity, 2002, 26: S18-S24.
  • 10Peyrot M. Resistance to insulin therapy among patients and providers: results of the cross national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care, 2005, 28: 2673-2679.

共引文献216

同被引文献47

  • 1郑雪枫,刘晓蓉.门冬胰岛素联合甘精胰岛素与胰岛素泵强化治疗2型糖尿病的疗效对比[J].医学信息(医学与计算机应用),2014,0(1):74-74. 被引量:3
  • 2马建华,李倩,李惠琴,李冬梅,陶小军,刘好,张颖,吴锦丹,毛晓明.甘精胰岛素与胰岛素泵的基础胰岛素剂量比较[J].医学研究生学报,2006,19(11):1004-1005. 被引量:4
  • 3中华医学会糖尿病学分会.中国2型糖尿病防治指南(2010年版)[J].中华糖尿病杂志,2010,2增刊2:1-56.
  • 4Shaw J E, Sicree R A, Zimmet P Z.Global estimates of theprevalence of diabetes for 2010 and 2030[J].Diabetes Res Clin Pract, 2010, 87(2): 4-14.
  • 5Yang W, Lu J, Weng J, et al.Prevanlence of diabetes among men and women in China[J].N Engl J Med, 2010, 362(3): 1090-1101.
  • 6Kendall D M, Cuddihy R M, Bergenstal R M.Clinieal application of ineretin-based therapy: therapeutic: potential, patient selection, and clinical use[J].Am J Med, 2009, 122(6 Suppl): S37-50.
  • 7Weng J, Li Y, Xu W, et al.Effeet of intensive insulin therapy on 3-cell function and glycaemic control in patients with newlydiagnosed type 2 diabetes: a multieentrerandomised parallel-group trial[J]. Lancet, 2008, 371(1): 1753-1760.
  • 8Garber A J, Abrahamson M J, Barzilayj I, et al.AmericanAssociation of Clinical Endocrinologists comprehensive diabetesmanagement algorithm 2013 consensus statementexecutivesummaryl[J].Endocr Pract, 2013, 47(19): 536-557.
  • 9Hooqwerf B J.Prioperative management of diabetes mellitius; how shouldwe act on the limited evdence[J].Cleve Clin J Med, 2006, 73(Suppl 1): 95-99.
  • 10Garber AJ, Abrahamson MJ,Barzilayj I,et al.American Associ- ation of Clinical Endocrinologists comprehensive diabetes manage- ment algorithm 2013 consensus statement executive summaryl[J]. Endocr Pract,2013,47(19):536-557.

引证文献6

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部